167 related articles for article (PubMed ID: 20943631)
1. New trends for staging and therapy for localized gastroesophageal cancer: the role of PET.
Lordick F; Ott K; Krause BJ
Ann Oncol; 2010 Oct; 21 Suppl 7():vii294-9. PubMed ID: 20943631
[TBL] [Abstract][Full Text] [Related]
2. The role of PET in predicting response to chemotherapy in oesophago-gastric cancer.
Lordick F
Acta Gastroenterol Belg; 2011 Dec; 74(4):530-5. PubMed ID: 22319962
[TBL] [Abstract][Full Text] [Related]
3. [Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
Lordick F; Ott K; Krause BJ
Dtsch Med Wochenschr; 2011 May; 136(20):1061-6. PubMed ID: 21560108
[No Abstract] [Full Text] [Related]
4. Positron emission tomography in gastric and esophageal cancer.
Flamen P
Curr Opin Oncol; 2004 Jul; 16(4):359-63. PubMed ID: 15187891
[TBL] [Abstract][Full Text] [Related]
5. Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
Kukar M; Alnaji RM; Jabi F; Platz TA; Attwood K; Nava H; Ben-David K; Mattson D; Salerno K; Malhotra U; Kanehira K; Gannon J; Hochwald SN
JAMA Surg; 2015 Jun; 150(6):555-62. PubMed ID: 25902198
[TBL] [Abstract][Full Text] [Related]
6. The value of 18F-FDG-PET testing in the management of esophageal and gastroesophageal junction adenocarcinoma - review.
Zemanová M; Obermannová R; Haruštiak T
Klin Onkol; 2021; 34(2):113-119. PubMed ID: 33906359
[TBL] [Abstract][Full Text] [Related]
7. Neoplasms of the esophagus and stomach.
Dehdashti F; Siegel BA
Semin Nucl Med; 2004 Jul; 34(3):198-208. PubMed ID: 15202101
[TBL] [Abstract][Full Text] [Related]
8. Perioperative EOX treatment in operable locally advanced gastroesophageal adenocarcinoma: Prediction of tumor response by FDG -PET and histopathology.
Vihervaara H; Ålgars A; Kemppainen J; Sundström J; Ristamäki R; Salminen P
Surg Oncol; 2019 Mar; 28():42-49. PubMed ID: 30851910
[TBL] [Abstract][Full Text] [Related]
9.
Lehmann K; Eshmuminov D; Bauerfeind P; Gubler C; Veit-Haibach P; Weber A; Abdul-Rahman H; Fischer M; Reiner C; Schneider PM
Eur J Surg Oncol; 2017 Jan; 43(1):196-202. PubMed ID: 27692533
[TBL] [Abstract][Full Text] [Related]
10. [Importance of PET in surgery of esophageal cancer].
Ott K; Schmidt T; Lordick F; Herrmann K
Chirurg; 2014 Jun; 85(6):505-12. PubMed ID: 24817185
[TBL] [Abstract][Full Text] [Related]
11. [Positron emission tomography in tumors of the upper gastrointestinal tract: controversial value].
Vallböhmer D; Hölscher AH
Dtsch Med Wochenschr; 2011 May; 136(20):1060. PubMed ID: 21560107
[No Abstract] [Full Text] [Related]
12. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
13. Application of positron emission tomography imaging to personalize esophagogastric cancer care.
Mondaca S; Janjigian YY
Cancer; 2019 Apr; 125(8):1214-1217. PubMed ID: 30668898
[No Abstract] [Full Text] [Related]
14. Utility of
Arnett ALH; Merrell KW; Macintosh EM; James SE; Nathan MA; Shen KR; Ravi K; Neben Wittich MA; Haddock MG; Hallemeier CL
J Thorac Oncol; 2017 Jan; 12(1):121-128. PubMed ID: 27569732
[TBL] [Abstract][Full Text] [Related]
15. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
Ott K; Weber WA; Lordick F; Becker K; Busch R; Herrmann K; Wieder H; Fink U; Schwaiger M; Siewert JR
J Clin Oncol; 2006 Oct; 24(29):4692-8. PubMed ID: 16966684
[TBL] [Abstract][Full Text] [Related]
16. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
[TBL] [Abstract][Full Text] [Related]
17. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
[TBL] [Abstract][Full Text] [Related]
18. Staging of adenocarcinoma of the gastroesophageal junction.
Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R
Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127
[TBL] [Abstract][Full Text] [Related]
19. Staging and Response Evaluation to Neo-Adjuvant Chemoradiation in Esophageal Cancers Using 18FDG PET/ CT with Standardized Protocol.
Fatima N; Zaman MU; Zaman A; Zaman U; Tahseen R; Zaman S
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2003-2008. PubMed ID: 31350957
[TBL] [Abstract][Full Text] [Related]
20. The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer.
van Rossum PS; Fried DV; Zhang L; Hofstetter WL; van Vulpen M; Meijer GJ; Court LE; Lin SH
J Nucl Med; 2016 May; 57(5):691-700. PubMed ID: 26795288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
